Venus Concept Inc (OQ:VERO)

Business Focus: Advanced Medical Equipment & Technology

Apr 15, 2024 07:30 am ET
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May...
Apr 08, 2024 07:30 am ET
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received approval for the Venus Bliss MAX from the State of Israel Ministry of Health. The Venus Bliss...
Apr 03, 2024 07:30 am ET
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic Goods Administration (TGA) clearance in Australia to market the Venus Versa Pro system. The...
Apr 01, 2024 07:00 am ET
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2023. Fourth Quarter and Fiscal Year 2023 Summary...
Mar 25, 2024 07:30 am ET
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the “Nasdaq Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to...
Mar 12, 2024 04:05 pm ET
Venus Concept Launches “NEXThetics” Program
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the launch of “NEXThetics”, its new series of customer education and training events. NEXThetics is the newest advancement...
Feb 27, 2024 04:05 pm ET
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for...
Feb 23, 2024 08:00 am ET
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 817,748 shares of common stock at a...
Feb 22, 2024 07:30 am ET
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received the CE Mark from DEKRA Certification B.V. to market the Venus Versa Pro system in the European...
Feb 20, 2024 07:30 am ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Monday, April...
Feb 06, 2024 07:30 am ET
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools...
Jan 24, 2024 07:30 am ET
Venus Concept Inc. Announces Review of Strategic Alternatives
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that its Board of Directors (the “Board”) is evaluating potential strategic alternatives to maximize shareholder...
Jan 23, 2024 08:31 am ET
Thinking about buying stock in Diversified Energy Co., Netflix, Salesforce, Shopify, or Venus Concept?
NEW YORK, Jan. 23, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DEC, NFLX, CRM, SHOP, and VERO.
Jan 19, 2024 07:30 am ET
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
Venus Concept, Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has issued new secured convertible notes to EW Healthcare Partners, L.P. and one of its affiliates (“EW...
Jan 17, 2024 07:30 am ET
Venus Concept Launches Venus Prime
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of Venus Prime, a structured in-house financing program replacing its legacy subscription program for new...
Dec 18, 2023 07:30 am ET
Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced the expansion of its international distributor network with the signing of two new exclusive partnerships: Core Aesthetics...
Nov 14, 2023 04:05 pm ET
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2023. Third Quarter 2023 Summary & Recent Progress:...
Nov 14, 2023 04:05 pm ET
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2023. Third Quarter 2023 Summary & Recent Progress:...
Nov 01, 2023 07:30 am ET
Venus Concept Launches Venus Versa Pro, its new multi-application platform for face and body treatments
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the commercial launch of its new multi-application platform Venus Versa Pro in the United States. Venus Versa Pro...
Oct 17, 2023 07:30 am ET
Venus Concept Launches New “Venus Aesthetic Intelligence” Branding and Updated “Venus.ai” Website to Reflect New Vision for the Company
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today a company-wide rebranding initiative, introducing Venus Aesthetic Intelligence (or "Venus AI") to reflect its new...
Oct 12, 2023 07:30 am ET
Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the promotion of Dr. Hemanth Varghese to the newly created role of President and Chief Operating Officer (COO),...
Oct 09, 2023 04:05 pm ET
Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2023 financial results will be released after the market closes on Tuesday,...
Oct 05, 2023 07:30 am ET
Venus Concept Inc. Announces Debt Restructuring, Preliminary Third Quarter 2023 Revenue Results and Updates Fiscal Year 2023 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has finalized an agreement with its lenders, City National Bank of Florida (“CNB”) and Madryn Asset...
Sep 14, 2023 07:00 am ET
Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its Venus Versa...
Sep 06, 2023 07:30 am ET
Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference, which is being...
Aug 14, 2023 04:05 pm ET
Venus Concept Announces Second Quarter of Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2023. Second Quarter 2023 Summary & Recent Progress:...
Jul 13, 2023 07:30 am ET
Venus Concept Announces Establishment of Medical Advisory Board For AI.ME™ -Its Next Generation Robotic Platform
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the establishment of a medical advisory board for AI.ME, its next generation robotic platform. The primary mission...
Jul 05, 2023 04:05 pm ET
Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August...
May 15, 2023 07:01 am ET
Venus Concept Announces First Quarter of Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2023. First Quarter 2023 Summary & Recent Highlights: Company...
May 15, 2023 07:00 am ET
Venus Concept Inc. Announces Multi-Tranche Private Placement of Senior Convertible Preferred Stock for up to $9 Million with EW Healthcare Partners
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into a stock purchase agreement (the “Stock Purchase Agreement”) with funds affiliated with EW...
May 11, 2023 08:30 am ET
Venus Concept Announces 1-for-15 Reverse Stock Split
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that its Board of Directors approved a 1-for-15 reverse stock split of the Company’s issued and outstanding common...
Apr 11, 2023 07:30 am ET
Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15,...
Mar 27, 2023 07:00 am ET
Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Summary & Recent...
Mar 20, 2023 07:00 am ET
Venus Concept Announces the Launch of its latest generation of ARTAS iX, the World’s Most Advanced Robotic Hair Restoration System
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of its latest generation of ARTAS iX, which is now broadly available to physicians specializing in hair...
Feb 08, 2023 07:30 am ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 27, 2023
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March...
Feb 07, 2023 07:00 am ET
Venus Concept Announces Strategic Business Realignment to Accelerate Its Path to Long-Term, Sustainable, Profitability and Reports Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2022
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced a restructuring plan, workforce reduction, management transition and reported preliminary unaudited revenue results...
Dec 21, 2022 07:00 am ET
Venus Concept Receives 510(k) Clearance for Use of its AI.ME™ Next Generation Robotic Technology for Fractional Skin Resurfacing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its...
Nov 18, 2022 08:30 am ET
Venus Concept Announces Completion of $6.72 Million Private Placement Financing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the “Private Placement”) of convertible preferred stock (the...
Nov 10, 2022 04:05 pm ET
Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2022. Third Quarter 2022 Summary & Operating...
Oct 19, 2022 04:05 pm ET
Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issued a stock option inducement grant to its President and Chief Business Officer, Hemanth...
Oct 11, 2022 07:30 am ET
Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Dr. Hemanth Varghese to the position of President & Chief Business Officer, effective October 17,...
Oct 06, 2022 05:50 pm ET
Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issued a stock option inducement grant to its Chief Executive Officer, Rajiv De Silva, upon the...
Oct 05, 2022 04:05 pm ET
Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it is updating the release date for its third quarter of fiscal year 2022 financial results. Third quarter...
Oct 03, 2022 07:00 am ET
Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Rajiv De Silva has been appointed as the Company’s Chief Executive Officer and a member of the Board of...
Aug 12, 2022 07:04 am ET
Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2022. Second Quarter 2022 Summary & Operating Highlights:...
Jun 30, 2022 07:30 am ET
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2022 financial results will be released before the market opens on Friday, August...
May 12, 2022 04:05 pm ET
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2022. First Quarter 2022 Summary & Recent Highlights: Total...
Apr 28, 2022 04:15 pm ET
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus...
Apr 25, 2022 07:05 am ET
Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that the first patient has been treated in a U.S. Investigational Device Exemption (IDE) clinical study evaluating...
Apr 04, 2022 04:05 pm ET
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2022 financial results will be released after the market closes on Thursday, May...
Mar 31, 2022 04:30 pm ET
Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced it has submitted a 510(k) premarket notification (“510(k)”) to the U.S. Food and Drug Administration ("FDA"), which...
Mar 28, 2022 07:00 am ET
Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2021. Fourth Quarter 2021 Summary & Recent...
Mar 21, 2022 04:05 pm ET
Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will present at the Maxim Virtual Growth Conference, which is being held virtually from March...
Feb 08, 2022 04:05 pm ET
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools...
Feb 02, 2022 07:30 am ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March...
Jan 18, 2022 04:05 pm ET
Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle Conditioning
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus...
Jan 10, 2022 07:00 am ET
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2021
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2021. Management Commentary: “Fourth...
Dec 15, 2021 09:00 am ET
Venus Concept Announces $17 Million Equity Financing led by Masters Special Situations
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the “Private Placement”) of common shares of the Company...
Nov 12, 2021 07:00 am ET
Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2021. Third Quarter 2021 Summary & Recent Highlights:...
Nov 10, 2021 04:05 pm ET
Venus Concept Inc. to Participate in the Stifel 2021 Virtual Healthcare Conference
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2021 Virtual Healthcare Conference. Management will participate in a...
Oct 19, 2021 07:30 am ET
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus Freedom...
Oct 12, 2021 07:30 am ET
Venus Concept Appoints Ross J. Portaro as President of Global Sales
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Ross J. Portaro to the position of President of Global Sales, effective October 15, 2021. Mr....
Oct 04, 2021 04:05 pm ET
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Friday, November 12,...
Sep 07, 2021 04:05 pm ET
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, which is being...
Aug 18, 2021 08:45 am ET
Sidoti Microcap Virtual Conference
Presentation Times Released for 50 Presenting CompaniesWednesday and Thursday, August 18-19, 2021
Aug 13, 2021 09:31 am ET
Thinking about buying stock in Biolase, Ziprecruiter, Romeo Power, Venus Concept, or Fulcrum Therapeutics?
NEW YORK, Aug. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOL, ZIP, RMO, VERO, and FULC.
Aug 13, 2021 07:05 am ET
Venus Concept Announces Second Quarter 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2021. Second Quarter 2021 Summary & Recent Highlights:...
Aug 12, 2021 04:05 pm ET
Venus Concept Inc. to Participate in the Sidoti & Co. Microcap Conference on August 18th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Sidoti & Co. Microcap Conference, which will be held virtually from August...
Jul 20, 2021 07:00 am ET
Venus Concept Announces Health Canada Authorization and CE Mark for Venus Fiore® Feminine Health System
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Fiore Feminine Health...
Jul 12, 2021 10:45 am ET
Venus Concept Inc. to Participate in the Ladenburg Thalmann Healthcare Conference on July 13th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Ladenburg Thalmann Healthcare Conference. Management will present at the...
Jul 08, 2021 04:05 pm ET
Venus Concept to Release Second Quarter of Fiscal Year 2021 Financial Results on August 13, 2021
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2021 financial results will be released before the market opens on Friday, August 13,...
May 17, 2021 04:05 pm ET
Venus Concept Announces First Quarter of 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2021. First Quarter 2021 Financial Summary:...
Apr 08, 2021 07:30 am ET
Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17, 2021....
Mar 29, 2021 04:05 pm ET
Venus Concept Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Reaffirms Fiscal Year 2021 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2020. Fourth Quarter 2020 Financial Summary: Total...
Mar 25, 2021 07:30 am ET
Venus Concept Announces Global Brand Ambassador Partnership with Tennis Champion and Entrepreneur Venus Williams
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Venus Williams, four-time Olympic Gold Medalist, seven-time Grand Slam Champion and entrepreneur, has signed on...
Mar 11, 2021 04:05 pm ET
Venus Concept Inc. to Participate in Two Upcoming Investor Conferences on March 17th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in March: The Oppenheimer 31st...
Mar 04, 2021 04:05 pm ET
Venus Concept Inc. to Present at the H.C. Wainwright Annual Global LifeSciences Conference on March 9th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will attend and present at the H.C. Wainwright Annual Global LifeSciences Conference, which is being...
Feb 09, 2021 07:30 am ET
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools...
Feb 08, 2021 04:05 pm ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 29, 2021
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Monday, March 29,...
Jan 14, 2021 06:30 am ET
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance...
Jan 05, 2021 04:05 pm ET
Venus Concept Inc. to Present at Two Upcoming Investor Conferences in January
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in January: The H.C. Wainwright...
Dec 22, 2020 08:55 am ET
Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering
Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000...
Dec 21, 2020 04:05 pm ET
Venus Concept Inc. Announces Proposed Public Offering
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants...
Dec 10, 2020 06:30 am ET
Venus Concept Announces Debt Refinancing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has amended its existing revolving credit facility with City National Bank of Florida (“CNB”) and...
Dec 01, 2020 04:05 pm ET
Venus Concept to Host Virtual “Aesthetic & Hair Restoration Technology” Event on December 10th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company will host a virtual “Aesthetic & Hair Restoration Technology” event on Thursday, December 10, 2020....
Nov 16, 2020 07:30 am ET
Venus Concept Announces Third Quarter and First Nine Months of 2020 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2020. Third Quarter 2020 Financial Summary: Total...
Nov 03, 2020 04:05 pm ET
Venus Concept Inc. to Present at the Stifel 2020 Virtual Healthcare Conference
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2020 Virtual Healthcare Conference. Management will present on...
Oct 15, 2020 04:05 pm ET
Venus Concept to Release Third Quarter of Fiscal Year 2020 Financial Results on November 16, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2020 financial results will be released before the market opens on Monday, November 16,...
Aug 13, 2020 04:05 pm ET
Venus Concept Announces Second Quarter and First Six Months of 2020 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2020. Second Quarter 2020 Financial Summary:  •Total GAAP...
Jul 16, 2020 07:30 am ET
Venus Concept Reports Preliminary Revenue Results for Second Quarter 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue results for the three months ended June 30, 2020. Management Commentary: “While our second...
Jul 01, 2020 04:05 pm ET
Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Viva MD
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD. Venus Viva MD is a non-invasive device...
Jun 26, 2020 07:30 am ET
Venus Concept Inc. Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company has been added to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes. The Company’s...
Jun 25, 2020 04:05 pm ET
Venus Concept to Release Second Quarter of Fiscal Year 2020 Financial Results on August 13, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, August 13,...
Jun 16, 2020 05:21 pm ET
Venus Concept Inc. Announces Common Stock Purchase Agreement for up to $31 Million with Lincoln Park Capital Fund, LLC
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into a common stock purchase agreement for up to $31 million with Lincoln Park Capital Fund, LLC...
Jun 15, 2020 07:30 am ET
Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Epileve
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received FDA 510(k) clearance to market and sell Venus Epileve. It is intended for treatment of hair...
May 14, 2020 04:05 pm ET
Venus Concept Announces First Quarter of 2020 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2020. The Company notes that the financial results provided for the...
Apr 15, 2020 04:05 pm ET
Venus Concept to Release First Quarter of Fiscal Year 2020 Financial Results on May 14, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, May 14,...
Mar 30, 2020 04:05 pm ET
Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the...
Mar 18, 2020 04:05 pm ET
Venus Concept Inc. Announces $22.25 Million Equity Financing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible...
Mar 10, 2020 04:01 pm ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30....
Mar 03, 2020 07:05 am ET
Venus Concept Expands Executive Team
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief...
Feb 14, 2020 04:05 pm ET
Venus Concept Inc. Announces New Regulatory Clearances
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks,...
Jan 13, 2020 07:00 am ET
Venus Concept Announces Preliminary Fourth Quarter and Fiscal Year 2019 Revenue Results; Introduces Fiscal Year 2020 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited revenue results for the three months and twelve months ended December 31, 2019 and introduced...
Dec 05, 2019 07:00 am ET
Venus Concept Inc. Announces CE Mark and Australian Regulatory Approval for NeoGraft 2.0, A Trusted Name in Hair Restoration
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a CE Mark from DEKRA Certification B.V. and Therapeutic Goods Administration (TGA) clearance in...
Nov 26, 2019 07:05 am ET
Venus Concept Inc. Announces CE Mark and Health Canada License to Market Venus Epileve
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada and CE Mark from DEKRA Certification B.V. to...
Nov 19, 2019 04:40 pm ET
Venus Concept Receives Health Canada Authorization to Market Venus Bliss in Canada
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market Venus Bliss™, a medical aesthetic...
Nov 14, 2019 04:07 pm ET
Venus Concept Announces Third Quarter and First Nine Months of 2019 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, provided standalone Venus Concept, Ltd. financial results for the third quarter and nine months ended September 30, 2019. The...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.